Technology News and Research

RSS

Boston Scientific launches iCross coronary imaging catheter

Boston Scientific Corporation has announced the launch of its iCross(TM) Coronary Imaging Catheter, a product designed to improve the deliverability of the Company's market-leading intravascular ultrasound (IVUS) technology, the iLab Ultrasound Imaging System.

20 Mar 2009

Olive oil loses some health benefits when stored for six months

That olive oil sitting on your shelf may lose up to 40 percent of its health benefits if it's been there for six months, according to a study presented in the March Journal of Food Science, published by the Institute of Food Technologists.

20 Mar 2009

Ultra-detailed 3-D images of eyes reveal details of age-related macular degeneration

To get a better look at the abnormalities that cause age-related macular degeneration (AMD), the leading cause of vision loss in Americans and Europeans over 50, the research groups of James Fujimoto at the Massachusetts Institute of Technology (MIT) and collaborators Jay Duker of the Tufts University School of Medicine, and Joel Schuman of the University of Pittsburgh School of Medicine have created ultra-detailed 3-D images of the eyes of more than 2,000 people from different ethnic groups, 400 of whom have AMD.

20 Mar 2009

Intradigm receives notice of allowance for key RNA interference patent covering potent siRNA sequence

Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, has announced that the United States Patent and Trademark Office (USPTO) has issued the company a notice of allowance for a patent covering various aspects of a potent small interfering RNA (siRNA) sequence.

17 Mar 2009

BioNanomatrix awarded phase II NIH grant to support development of single-molecule nanoscale whole genome analyzer

BioNanomatrix, Inc. has announced receipt of a Phase II grant from the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health (NIH).

17 Mar 2009

Engineering flu vaccines

A new computerized method of testing could help world health officials better identify flu vaccines that are effective against multiple strains of the disease.

17 Mar 2009

Alba Therapeutics announces next clinical trial of lead compound, Larazotide Acetate

Alba Therapeutics Corporation announced today it will initiate further clinical studies for patients diagnosed with celiac disease with their lead compound, larazotide acetate.

17 Mar 2009

FDA looks at nanotechnology for the detection of anthrax

The U.S. Food and Drug Administration has completed a "proof-of-concept" study of a test that quickly and accurately detects the presence of even the smallest amount of the deadly anthrax toxin.

17 Mar 2009

Examining the infinitesimal - new approach to microscopy

A new approach to microscopy is opening up the wonders of the molecular world, allowing researchers to examine organic molecules and delicate crystals as they grow, atom by atom. Dr Andrew Humhpris, co-founder of the original technology and now Chief Technology Officer of Infinitesima, explains how this University spin-out has turned into a leading-edge company.

17 Mar 2009

Sensitive new test for protein detection

Scientists at the Naval Research Laboratory (NRL) recently reported the detection of toxins with unprecedented speed, sensitivity, and simplicity.

16 Mar 2009

Tiny probes help track down and attack cancer cells

A researcher has developed probes that can help pinpoint the location of tumors and might one day be able to directly attack cancer cells.

16 Mar 2009

First treatment for muscular dystrophy a step closer

Genetic researchers at Children's National Medical Center and the National Center of Neurology and Psychiatry in Tokyo published the results of the first successful application of "multiple exon-skipping" to curb the devastating effects of Duchenne muscular dystrophy in an animal larger than a mouse.

16 Mar 2009

Drugs throw spanner into the molecular works of enzymes

Drugs that work by blocking the function of a protein from the outside also disrupt the protein's internal workings, according to new research from the University of North Carolina at Chapel Hill.

16 Mar 2009

ATCC develops and isolates novel avian flu monoclonal antibodies

ATCC (American Type Culture Collection) researchers have developed a panel of novel monoclonal antibodies (mAbs) against avian influenza viruses. These antibodies could lead to a rapid diagnostic test for the infection, ATCC announced today. The organization has filed a patent covering the development of these novel antibodies.

16 Mar 2009

FDA approves new version of St. Jude Medical internet-based remote care system for implanted medical devices

St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) approval of the newest version of the Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.

16 Mar 2009

Novel genetic technology for canine form of muscular dystrophy

Using a novel genetic technology that covers up genetic errors, researchers funded in part by the National Institutes of Health have developed a successful treatment for dogs with the canine version of Duchenne muscular dystrophy, a paralyzing, and ultimately fatal, muscle disease.

16 Mar 2009

University of Florida doctors test targets for Parkinson surgery

Doctors may be able to tailor a specialized form of brain surgery to more closely match the needs of Parkinson patients, according to results from the first large-scale effort to compare the two current target areas of deep brain stimulation surgery, or DBS.

15 Mar 2009

Proteomics study shows that genes involved in invertebrate longevity have surprising parallels in humans

Prolexys Pharmaceuticals has announced the publication of the discovery of genes that are likely to have a role in the aging process of humans.

15 Mar 2009

Nobilon's intranasal influenza vaccine begins phase I clinical development

Nobilon, the human vaccine business unit of Schering-Plough Corporation has announced that it has reached an important milestone with the initiation of its first-in-human clinical development program for SCH 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) for annual seasonal use.

15 Mar 2009

Bioabsorbable stents show promise

A study published online in The Lancet presented two year data for the bioabsorbable everolimus coronary stent.

15 Mar 2009

Technology News and Research

Boston Scientific launches iCross coronary imaging catheter

Olive oil loses some health benefits when stored for six months

Ultra-detailed 3-D images of eyes reveal details of age-related macular degeneration

Intradigm receives notice of allowance for key RNA interference patent covering potent siRNA sequence

BioNanomatrix awarded phase II NIH grant to support development of single-molecule nanoscale whole genome analyzer

Engineering flu vaccines

Alba Therapeutics announces next clinical trial of lead compound, Larazotide Acetate

FDA looks at nanotechnology for the detection of anthrax

Examining the infinitesimal - new approach to microscopy

Sensitive new test for protein detection

Tiny probes help track down and attack cancer cells

First treatment for muscular dystrophy a step closer

Drugs throw spanner into the molecular works of enzymes

ATCC develops and isolates novel avian flu monoclonal antibodies

FDA approves new version of St. Jude Medical internet-based remote care system for implanted medical devices

Novel genetic technology for canine form of muscular dystrophy

University of Florida doctors test targets for Parkinson surgery

Proteomics study shows that genes involved in invertebrate longevity have surprising parallels in humans

Nobilon's intranasal influenza vaccine begins phase I clinical development

Bioabsorbable stents show promise

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News